Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

1,366.40INR
10:25am GMT
Change (% chg)

Rs11.15 (+0.82%)
Prev Close
Rs1,355.25
Open
Rs1,341.75
Day's High
Rs1,390.00
Day's Low
Rs1,323.80
Volume
8,534
Avg. Vol
31,051
52-wk High
Rs1,800.05
52-wk Low
Rs1,010.00

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Underperform -- March 11 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 6 6 6 6
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 3.55 3.55 3.55 3.55

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 1 8,215.00 8,215.00 8,215.00 --
Year Ending Mar-18 9 30,763.50 32,896.20 29,140.00 --
Year Ending Mar-19 8 33,218.20 37,704.90 31,555.00 35,858.90
Year Ending Mar-20 7 36,500.00 39,698.00 34,643.00 39,335.00
Earnings (per share)
Year Ending Mar-18 9 21.16 24.55 18.75 --
Year Ending Mar-19 8 26.31 30.60 22.53 26.09
Year Ending Mar-20 7 30.97 39.60 25.21 29.08

Historical Surprises

No historical surprise data available.

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 8,215.00 -- -- -- --
Year Ending Mar-18 30,763.50 -- -- -- --
Year Ending Mar-19 33,218.20 33,218.20 33,068.80 33,152.40 35,858.90
Year Ending Mar-20 36,500.00 36,500.00 36,479.40 36,746.40 39,335.00
Earnings (per share)
Year Ending Mar-18 21.16 -- -- -- --
Year Ending Mar-19 26.31 26.31 26.17 26.57 26.09
Year Ending Mar-20 30.97 30.97 30.78 31.42 29.08

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 -- -- -- --
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 0 0 0 0
Year Ending Mar-20 0 0 0 0
Earnings
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 0 0 0 0
Year Ending Mar-20 0 0 0 0